Document:

EX-10.1

 Exhibit 10.1 

2012 Genworth Financial, Inc. Omnibus Incentive Plan 

2017-2019 Performance Stock Unit Award Agreement 
  

 
 Dear [Participant Name]: 

You have been selected to receive an Award under the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “Plan”), on the terms and
conditions set forth below. This Award Agreement and the Plan together govern your rights under this Award and set forth all of the conditions and limitations affecting such rights. Unless the context otherwise requires, capitalized terms used in
this Award Agreement shall have the meanings ascribed to them in the Plan. If there is any inconsistency between the terms of this Award Agreement and the terms of the Plan, the Plan’s terms shall supersede and replace the conflicting terms of
this Award Agreement. 
  

	1.	Grant of Performance Stock Units. You are hereby granted performance stock units (“Units”), representing the right to earn, on a one-for-one basis, Shares of the Company’s Class A common stock (“Shares”), all in accordance with the terms of this Award Agreement, the Plan, and any rules and procedures adopted
by the Committee. The Units represent the right to earn from 0% to 150% of the Target Award, based on (i) your continued future employment, and (ii) the Company’s level of achievement of the Performance Goals during the Performance
Period, in accordance with the terms of this Award Agreement. 

  

	 	a.	Grant Date. The Grant Date of your Units is [            ], 2017. 

 

	 	b.	Target Award. The Target Award of Shares subject to this Award is [                    ].

  

	 	c.	Performance Goals. The Performance Goals are described on Exhibit A. 

  

	 	d.	Performance Period. The Performance Period is the three-year period beginning January 1, 2017 and ending December 31, 2019, with three discrete and independent Performance Measurement
Periods running sequentially from January 1 through December 31 of each calender year within the performance period. 

  

	2.	Agreement to Participate. You have been provided with this Agreement, and you have the opportunity to accept this agreement, by accessing and following the procedures set forth on the stock plan
administrator’s website. The Plan is available for your reference on the stock plan administrator’s website. You may also request a copy of the Plan at any time by contacting Human Resources at the address or telephone number set forth
below in Section 11(a). By agreeing to participate, you acknowledge that you have reviewed the Plan and this Award Agreement, and you fully understand all of your rights under the Plan and this Award Agreement, the Company’s remedies if you
violate the terms of this Award Agreement, and all of the terms and conditions which may limit your eligibility to retain and receive the Units and/or Shares issued pursuant to the Plan and this Award Agreement. 

If you do not wish to accept the Units and participate in the Plan and be subject to the provisions of the Plan and this Award Agreement,
please contact the Human Resources Department, Genworth Financial, Inc., 6620 W. Broad Street, Richmond, VA 23230, or at (804) 281-6000, within thirty (30) days of receipt of this Award Agreement. If you
do not respond within thirty (30) days of receipt of this Award Agreement, the Award Agreement is deemed accepted. If you choose to participate in the Plan, you agree to abide by all of the governing terms and provisions of the Plan and this
Award Agreement 
  

	3.	Earning and Vesting of Units. The Units shall not provide you with any rights or interests therein until the Units have been earned and vested. Not later than March 15 following the end
of the Performance Period (the “Vesting Date”), the Committee shall determine and certify the level of achievement of the Performance Goals, and determine the number of Units earned and vested (“Confirmed Units”).
Any Units that fail to vest in accordance with the terms of this Award Agreement will be forfeited and reconveyed to the Company without further consideration or any act or action by you. 

	4.	Conversion to Shares. The Confirmed Units shall automatically convert to Shares on the Vesting Date (the “Conversion Date”). These Shares will be registered on the books of
the Company in your name as of the Conversion Date, and the Company shall deliver to you a certificate or certificates, or evidence of book entry, with respect to such Shares. 

If for any reason the Committee is unable to certify the level of achievement of the Performance Goals by March 15 following the end of
the Performance Period, then the Vesting Date shall be March 15 following the end of the Performance Period, but the determination of the number of Confirmed Units and the Conversion Date shall be delayed, in the discretion of the Committee,
for such period as may be required for the Committee to certify the level of achievement of the Performance Goals, but in no event shall the Conversion Date extend beyond December 31, 2020. 

 

	5.	Treatment of Units Upon Termination of Employment. Subject to Section 6 below, the Units shall be immediately and automatically cancelled upon termination of
your service with the Company and its Affiliates prior to the Vesting Date, for any reason other than your death, Total Disability or Retirement on or after the first anniversary of the grant date. If your service with the Company and its Affiliates
terminates prior to the Vesting Date as a result of your death, Total Disability or Retirement on or after the first anniversary of the grant date, then the Award shall fully vest as of your termination date, and you (or your estate, in the event of
your death) shall receive a pro rata payout on the regular Conversion Date, determined by multiplying the Confirmed Shares that otherwise would have paid out based on actual performance for the entire Performance Period, multiplied by a fraction,
the numerator of which is the number of full months elapsed from January 1, 2017 until the date of your termination, and the denominator of which is 36. 

For purposes of this Award Agreement, the following terms shall have the following meanings: 

“Retirement” shall mean your voluntary resignation on or after you have attained age sixty (60) and
accumulated five (5) or more years of combined and continuous service with the Company. 
 “Total
Disability” shall mean a permanent disability that would make you eligible for benefits under the long-term disability program maintained by the Company or any of its Affiliates (without regard to any time period during which the
disabling condition must exist) or in the absence of any such program, such meaning as the Committee shall determine. 
  

	6.	Change of Control. In the event of a Change of Control of the Company (as defined in the Plan), the Units shall be treated as set forth in this Section 6. 

 

	 	a.	Qualifying Change of Control and Awards are Not Assumed. Upon the occurrence of a Qualifying Change of Control (as defined below) on or after the first anniversary of the Grant Date in which
the Successor Entity fails to Assume and Maintain this Award of Units, the Units shall immediately vest as of the effective date of such Qualifying Change of Control; shall be deemed earned based on actual pro rata performance as of the date of such
Qualifying Change of Control, to the extent such performance can be reasonably established in the sole discretion of the Committee, or otherwise based on an assumed achievement of all relevant performance goals at “target” levels, if
actual pro rata performance cannot be reasonably established in the sole discretion of the Committee; shall be distributed or paid to you within thirty (30) days following the date of the Qualifying Change of Control pro rata based on the
portion of the performance period elapsed on the date of the Qualifying Change of Control in cash, Shares (based on the value of the Shares as of the effective date of the Change of Control), other securities, or any combination, as determined by
the Committee; and shall thereafter terminate, provided that the circumstances giving rise to such Qualifying Change of Control meet the definition of a “change in control event” under Code Section 409A. 

  
 2 

	 	b.	Employment Termination without Cause or for Good Reason within 12 Months of a Qualifying Change of Control. If a Qualifying Change of Control occurs and the Successor Entity Assumes and Maintains
this Award of Units, and if your service with the Successor Entity and its Affiliates is terminated on or after the first anniversary of the Grant Date by the Successor Entity or one of its Affiliates without Cause (other than such termination
resulting from your death or Disability) or by you for Good Reason (as such terms are defined below) within twelve (12) months following the effective date of such Qualifying Change of Control, then the Units shall immediately vest as of the
date of termination of your service with the Successor Entity and its Affiliates; shall be deemed earned based on actual pro rata performance as of the date of termination of your service with the Company and its Affiliates, to the extent such
performance can be reasonably established in the sole discretion of the Committee, or otherwise based on an assumed achievement of all relevant performance goals at “target” levels, if actual pro rata performance cannot be reasonably
established in the sole discretion of the Committee; shall be distributed or paid to you within thirty (30) days following the date of termination of your service with the Successor Entity and its Affiliates pro rata based on the portion of the
performance period elapsed as of the termination of your service with the Successor Entity and its Affiliates; and shall thereafter terminate. 

  

	 	c.	Employment Termination without Cause or for Good Reason within 12 Months of a Non-Qualifying Change of Control. If a
Non-Qualifying Change of Control (as defined below) occurs and if your service with the Company and its Affiliates is terminated on or after the first anniversary of the Grant Date by the Company or one of its
Affiliates without Cause (other than such termination resulting from your death or Disability) or by you for Good Reason within twelve (12) months following the effective date of the Non-Qualifying Change
of Control, then the Units shall immediately vest as of the date of termination of your service with the Company and its Affiliates; shall be deemed earned based on actual pro rata performance as of the date of termination of your service with the
Company and its Affiliates, to the extent such performance can be reasonably established in the sole discretion of the Committee, or otherwise based on an assumed achievement of all relevant performance goals at “target” levels, if actual
pro rata performance cannot be reasonably established in the sole discretion of the Committee; shall be distributed or paid to you within thirty (30) days following the date of termination of your service with the Company and its Affiliates pro
rata based on the portion of the performance period elapsed on the date of the Change of Control; and shall thereafter terminate. 

  

	 	d.	Defined Terms. For purposes of this Award Agreement: 

  

	 	(i)	“Business Unit Sale” shall mean the Company’s sale or disposition of all or any portion of a business unit. 

 

	 	(ii)	“Cause” shall mean (i) your willful and continued failure to substantially perform your duties with the Company and its Affiliates (other than any such failure resulting from
your Disability); (ii) your commission, conviction or pleading guilty or nolo contendere (or any similar plea or admission) to any felony or any act of fraud, misappropriation or embezzlement; (iii) your willful engagement in conduct (other
than conduct covered under clause (i) above) which, in the good faith judgment of the Committee, is injurious to the Company and/or its Affiliates, monetarily or otherwise; or (iv) your material violation or breach of any Company or
Affiliate policy, or any noncompetition, confidentiality, or other restrictive covenant with respect to the Company or any of its Affiliates, that applies to you; provided, however, that for purposes of clauses (i) and (ii) of
this definition, no act, or failure to act, on your part shall be deemed “willful” unless done, or omitted to be done, by you not in good faith and without reasonable belief that the act, or failure to act, was in the best interests of the
Company and/or its Affiliates. 

  

	 	(iii)	“Good Reason” shall mean any material reduction in the aggregate value of your compensation (including base salary and bonus), or a substantial reduction in the aggregate value of
benefits provided to you; provided, however, that Company-initiated across-the-board reductions in compensation or benefits affecting substantially all employees shall
alone not be considered Good Reason. 

  
 3 

	 	(iv)	“Non-Qualifying Change of Control” shall mean a Change of Control of the Company (as defined in the Plan) that results from a Business Unit
Sale, provided that following such Change of Control (i) the Company remains in existence as a publicly-traded company (separate and apart from any Successor Entity resulting from the Change of Control, and regardless of whether the Company
continues to use the name “Genworth Financial, Inc.” or a different name), (ii) your employment with the Company is not terminated by the Company or one of its Affiliates without Cause in connection with the Change in Control, and
(iii) the Units subject to this Agreement remain outstanding. 

  

	 	(v)	“Qualifying Change of Control” shall mean a Change of Control of the Company (as defined in the Plan) that is not a Non-Qualifying Change of
Control. 

  

	7.	Payment of Taxes. The Company or any of its Affiliates employing you has the authority and the right to deduct or withhold, or require you to remit to the employer, an amount sufficient to satisfy
federal, state, and local taxes (including your FICA obligation) required by law to be withheld with respect to any taxable event arising as a result of the vesting or payment of this Award. With respect to such withholding, the employer may satisfy
the tax withholding requirement by withholding Shares having a Fair Market Value as of the date that the amount of tax to be withheld is to be determined as nearly equal as possible to the total minimum statutory tax required to be withheld (or such
greater amount up to the maximum individual statutory rate in the applicable jurisdiction as may be permitted under then-current accounting principles to qualify for equity classification), all in accordance with such procedures as the Committee
establishes. The obligations of the Company under this Award Agreement will be conditional on such payment or arrangements, and the Company, and, where applicable, its Affiliates will, to the extent permitted by law, have the right to deduct any
such taxes from any payment of any kind otherwise due to you. 

  

	8.	Nontransferability. This Award may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (“Transfer”), other than by will or by the laws of
descent and distribution, except as provided in the Plan. If any prohibited Transfer, whether voluntary or involuntary, of the Award is attempted to be made, or if any attachment, execution, garnishment, or lien shall be attempted to be issued
against or placed upon this Award, your right to receive any payment pursuant to the terms of this Award shall be immediately and automatically be forfeited, and this Award Agreement shall be null and void. 

 

	9.	Administration. This Award Agreement and your rights hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to time, as well as to such rules
and regulations as the Committee may adopt for administration of the Plan. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Plan
and this Award Agreement, all of which shall be binding upon you. The Committee’s interpretation of the Plan and this Award Agreement, and all decisions and determinations by the Committee with respect to the Plan and this Award Agreement,
shall be final, binding, and conclusive on all parties. 

  

	10.	Limitation of Rights. The Units do not confer to you or your beneficiary, executors or administrators any rights of a stockholder of the Company unless and until Shares are in fact issued to
such person in connection with the Units. This Award Agreement shall not confer upon you any right to continuation of employment by the Company or any of its Affiliates, nor shall this Award Agreement interfere in any way with the Company’s or
any of its Affiliate’s right to terminate your employment at any time. 

  

	11.	Plan; Prospectus and Related Documents; Electronic Delivery. 

  

	 	a.	A copy of the Plan will be furnished upon written or oral request made to the Human Resources Department, Genworth Financial, Inc., 6620 W. Broad Street, Richmond, VA 23230, or telephone (804) 281-6000. 

  
 4 

	 	b.	As required by applicable securities laws, the Company is delivering to you a prospectus in connection with this Award, which delivery is being made electronically. A paper copy of the prospectus may also be
obtained without charge by contacting the Human Resources Department at the address or telephone number listed above. By accepting this Award Agreement, you shall be deemed to have consented to receive the prospectus electronically.

  

	 	c.	The Company will deliver to you electronically a copy of the Company’s Annual Report to Stockholders for each fiscal year, as well as copies of all other reports, proxy statements and other communications
distributed to the Company’s stockholders. You will be provided notice regarding the availability of each of these documents, and such documents may be accessed by going to the Company’s website at www.genworth.com and clicking on
“Investors” and then “SEC Filings & Financial Reports” (or, if the Company changes its web site, by accessing such other web site address(es) containing investor information to which the Company may direct you in the
future) and will be deemed delivered to you upon posting or filing by the Company. Upon written or oral request, paper copies of these documents (other than certain exhibits) may also be obtained by contacting the Company’s Human Resources
Department at the address or telephone number listed above or by contacting the Investor Relations Department, Genworth Financial, Inc., 6620 W. Broad Street, Richmond, VA 23230, or telephone (804) 281-6000.

  

	 	d.	By accepting this Award, you agree and consent, to the fullest extent permitted by law, in lieu of receiving documents in paper format to accept electronic delivery of any documents that the Company may be
required to deliver in connection with this Award and any other Awards granted to you under the Plan. Electronic delivery of a document may be via a Company e-mail or by reference to a location on a Company
intranet or internet site to which you have access. 

  

	12.	Amendment, Modification, Suspension, and Termination. Subject to the terms of the Plan, this Agreement may be modified or amended by the Committee; provided that no such amendment shall
materially and adversely affect your rights hereunder without your consent. Notwithstanding the foregoing, you hereby expressly agree to any amendment to the Plan and this Agreement to the extent necessary to comply with applicable law or changes to
applicable law (including, but not limited to, Code Section 409A) and related regulations or other guidance and federal securities laws. 

  

	13.	Applicable Law. The validity, construction, interpretation, and enforceability of this Award Agreement shall be determined and governed by the laws of the State of Delaware without
giving effect to the principles of conflicts of law. For purposes of litigating any dispute that arises under this grant or the Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Virginia, and agree that
such litigation shall be conducted in the courts of Richmond, Virginia or the federal courts for the United States for the Eastern District of Virginia, where this Award is made and/or to be performed. 

 

	14.	Entire Agreement; Plan Controls. This Award Agreement, the Plan, and the rules and procedures adopted by the Committee contain all of the provisions applicable to the Award and no other
statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to you. In the event of any actual or alleged conflict between the
provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall be controlling and determinative. 

  

	15.	Compensation Recoupment Policy. This Award shall be subject to any compensation recoupment policy of the Company that is applicable by its terms to you and to Awards of this type. 

 

	16.	Successors. This Award Agreement shall be binding upon any successor of the Company, in accordance with the terms of this Award Agreement and the Plan. 

PLEASE REFER ANY QUESTIONS YOU MAY HAVE REGARDING YOUR PERFORMANCE STOCK UNIT AWARD TO THE EXECUTIVE VICE PRESIDENT OF HUMAN RESOURCES. 

  
 5 

 Exhibit A 

2017-2019 Performance Stock Unit Award Defined Terms 

2017-2019 Performance Stock Unit Award Goals 
  

																	
	 ($ in Millions)
	  	 	 	 	[Performance Measure]	 
	 Performance

Measurement Period
	  	Weight
(% of
Target)	 	 	Threshold
(50% Payout)	 	  	Target
(100% Payout)	 	  	Maximum
(150% Payout)	 
	 January 1, 2017 – December 31, 2017
	  	 	34	% 	 	$	[            	] 	  	$	[            	] 	  	$	[            	] 
	 January 1, 2018 – December 31, 2018
	  	 	33	% 	 	$	[            	] 	  	$	[            	] 	  	$	[            	] 
	 January 1, 2019 – December 31, 2019
	  	 	33	% 	 	$	[            	] 	  	$	[            	] 	  	$	[            	] 

  

	 	•	 	Performance under each Performance Measurement Period is independently weighted, with the results for each Performance Measurement Period are multiplied by the applicable weightings and then added together.

  

	 	•	 	Payout for performance between points is interpolated on a straight-line basis. 

  

	 	•	 	No payout shall be earned for performance below threshold level for a given Performance Measurement Period. 

  

	 	•	 	In evaluating performance, the committee shall exclude the impact, if any, on reported financial results of any of the following events that occur during the performance period: a) acquisitions and divestitures, b)
shareholder dividends or common stock repurchases and c) changes in accounting principles or other laws or provisions. 

  

	 	•	 	Notwithstanding the level of achievement of the above Performance Goals, the Committee may exercise negative discretion to pay out a lesser amount, or no amount at all, under the Performance Stock Unit Award, based on
such considerations as the Committee deems appropriate.Exhibit 4.1

 

THIS WARRANT AND ANY SECURITIES ACQUIRED UPON EXERCISE OF THIS WARRANT
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND NONE OF THIS WARRANT,
SUCH SECURITIES OR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS.

 

THIS WARRANT AND THE SECURITIES ACQUIRED UPON EXERCISE OF THIS WARRANT
ARE SUBJECT TO THE CONDITIONS ON TRANSFER AND OTHER TERMS AND CONDITIONS SPECIFIED BELOW
and IN the CERTIFICATE OF INCORPORATION of THE ISSUER HEREOF (THE “COMPANY”), AS AMENDED FROM TIME TO TIME.
UPON WRITTEN REQUEST, A COPY OF SUCH CONDITIONS WILL BE FURNISHED BY THE COMPANY TO THE HOLDER HEREOF WITHOUT CHARGE.

 

WARRANT

 

	Issuance Date: April 3, 2017	Certificate No. [W-001/W-002]

 

FOR VALUE RECEIVED, Sterling Construction Company,
Inc., a Delaware corporation (the “Company”), hereby grants to [OCM Sterling NE Holdings, LLC/OCM Sterling E
Holdings, LLC] or its registered assigns (the “Registered Holder”) the right, upon the terms and subject to
the conditions set forth herein, to purchase from the Company up to [three hundred eighty-three thousand six hundred fifty (383,650)/six
hundred sixteen thousand three hundred fifty (616,350)] shares of common stock of the Company (such common stock or any successor
interest for which this warrant is exercisable, as may be further adjusted from time to time in accordance herewith, the “Exercise
Stock”), at a price per share equal to the Exercise Price; provided that the Registered Holder may exercise this
Warrant on a “net” basis by paying the Aggregate Exercise Price (as defined below) by delivering to the Company a portion
of this Warrant with a Market Price equal to such Aggregate Exercise Price. Certain capitalized terms used herein are defined in
Section 6. The amount and kind of securities purchasable pursuant to the rights granted hereunder and the purchase price
for such securities are subject to adjustment pursuant to the provisions contained in this Warrant. This Warrant is being issued
in connection with the Loan Agreement (as defined below), as required therein, and a Registration Rights Agreement, dated as of
the date hereof, between the Registered Holder and the Company (the “Registration Rights Agreement”) is concurrently
being entered into in order to permit the transfer of the Exercise Stock.

This Warrant is subject to the following provisions:

 

Section 1.   
Exercise of Warrant. 

 

1A.           
Exercise Period and Amount. The Registered Holder or the Purchaser (as defined below) may exercise, in whole or in
part, the purchase rights for the Exercise Stock represented by this Warrant at any time, and from time to time up to and including
the Expiration Date (the “Exercise Period”). To the extent this Warrant is not previously exercised as to all
the Exercise Stock subject hereto, and if the then-current Market Price of one share of the Company’s common stock is greater
than the Exercise Price then in effect, then immediately prior to the Expiration Date, this Warrant shall be deemed automatically
exercised on a “net basis” basis pursuant to Section 1B(i)(e) (even if not surrendered).

 

     

     

    

 

1B.            
Exercise Procedure. 

 

(i)                
This Warrant shall be deemed to have been exercised when the Company has received all of the following items during the
Exercise Period (the “Exercise Time”):

(a)               
a completed Exercise Agreement, as described in Section 1C (the “Exercise Agreement”), executed
by the Person exercising all or part of the purchase rights represented by this Warrant (the “Purchaser”);

 

(b)              
this Warrant;

 

(c)               
if this Warrant is not registered in the name of the Purchaser, an assignment or assignments substantially in the form set
forth on Exhibit I attached hereto evidencing the assignment of this Warrant to the Purchaser, in which case this Warrant
may be exercised only if the Registered Holder shall have complied with the provisions set forth in Section 8;

 

(d)              
unless this Warrant is being exercised on a “net basis,” a check or wire transfer of immediately available funds
in an amount equal to the product of the Exercise Price multiplied by the number of shares of the Exercise Stock being purchased
upon such exercise (the “Aggregate Exercise Price”); and

 

(e)               
if this Warrant is being exercised on a “net basis,” in lieu of payment of the Aggregate Exercise Price, the
number of shares of the Exercise Stock issuable upon exercise of this Warrant shall be reduced by a number of shares of the Exercise
Stock with a Market Price equal to the Aggregate Exercise Price.

 

(ii)              
Within five business days after the Exercise Time, the Company shall deliver an instruction letter to the Company’s
transfer agent instructing that the Exercised Stock purchased upon exercise of this Warrant shall be recorded electronically in
the name of the Purchaser. Unless this Warrant has expired or all of the rights represented hereby have been exercised, the Company
shall prepare a new Warrant, substantially identical hereto, representing the rights formerly represented by this Warrant which
have not expired or been exercised and shall, within such five business day period, deliver such new Warrant to the Registered
Holder.

 

(iii)            
The Exercise Stock shall be deemed to have been issued to the Purchaser at the Exercise Time, and the Purchaser shall be
deemed for all purposes to have become the record holder of such Exercise Stock at the Exercise Time.

 

(iv)            
The issuance of the Exercise Stock shall be made without charge to the Registered Holder or the Purchaser for any tax with
respect to such issuance or any cost incurred by the Company in connection with such exercise and the related issuance of the Exercise
Stock. Each share of the Exercise Stock will, upon exercise of this Warrant in accordance with the terms hereof and payment of
the Exercise Price therefor, be fully paid and nonassessable by the Company and free from all taxes, liens and charges with respect
to the issuance thereof.

 

    	- 2 -

     

    

(v)              
The Company shall assist and cooperate with any Registered Holder or Purchaser required to make any governmental filings
or obtain any governmental approvals prior to or in connection with any exercise of this Warrant (including, without limitation,
making any filings required to be made by the Company). Any such governmental filings or approvals required prior to or in connection
with the exercise of this Warrant shall be made or obtained at the Company’s expense.

 

(vi)            
The Company shall give the Registered Holder at least 30 days’ advance written notice of the date on which a Sale
of the Company would become effective. To the extent this Warrant is not previously exercised as to all the Exercise Stock subject
hereto, and if the then-current Market Price of one share of the Company’s common stock is greater than the Exercise Price
then in effect, this Warrant shall be deemed automatically exercised on a “net basis” basis pursuant to Section
1B(i)(e) (even if not surrendered) as of immediately prior to the consummation of a Sale of the Company. In addition, in connection
with a Sale of the Company, the Company agrees to allow the Registered Holder to participate in such Sale of the Company without
the exercise of this Warrant.

 

(vii)          
Notwithstanding anything to the contrary in Section 2E, in connection with any Organic Change following which the
Registered Holder would not be entitled to exercise the Warrant for shares of stock that are listed on any domestic securities
exchange, the Registered Holder may, in lieu of the adjustment mechanism in Section 2E, elect to terminate this Warrant
and exchange the Warrant for cash proceeds in an amount equal to the Exercise Stock multiplied by the difference between the Market
Price immediately prior to such Organic Change and the Exercise Price, with such cash to be paid by the Company (or the successor
entity or purchasing entity). Such election must be made, if at all, on or prior to the effective date of such Organic Change.

 

(viii)        
The Company shall at all times reserve and keep available out of its authorized but unissued common stock, solely for the
purpose of issuance upon the exercise of this Warrant, such number of shares of the Exercise Stock issuable upon the exercise of
this Warrant (and any other warrants issued by the Company). All shares of the Exercise Stock that are so issuable shall, when
issued in accordance with the terms of this Warrant, be duly and validly issued, fully paid and nonassessable by the Company and
free from all taxes, liens and charges with respect to the issuance thereof. The Company shall take all such actions as may be
necessary to assure that all such shares of the Exercise Stock may be so issued without violation of any Applicable Law or any
requirements of any domestic securities exchange upon which the Exercise Stock may be listed (except for official notice of issuance
which shall be immediately delivered by the Company upon each such issuance). The Company shall not take any action which would
cause the number of authorized but unissued shares of the Company’s common stock to be less than the number of shares of
the Exercise Stock required to be reserved hereunder for issuance upon exercise of this Warrant (and any other warrants issued
by the Company).

 

1C.            
Exercise Agreement. Upon any exercise of this Warrant, the Exercise Agreement shall be substantially in the form
set forth on Exhibit II attached hereto, except that if the shares of Exercise Stock are not to be issued in the name of
the Person in whose name this Warrant is registered, the Exercise Agreement shall also state the name of the Person to whom the
certificates for the Exercise Stock are to be issued, and if the number of the Exercise Stock to be issued does not include all
the Exercise Stock purchasable hereunder, the Exercise Agreement shall also state the name of the Person to whom a new Warrant
for the unexercised portion of the rights hereunder is to be delivered. Such Exercise Agreement shall be dated the actual date
of execution thereof and shall indicate whether the Aggregate Exercise Price is to be paid in cash or on a “net basis”.

 

    	- 3 -

     

    

Section 2.   
Adjustment of Exercise Price and Number of Shares. In order to prevent dilution of the rights granted under this
Warrant, the Exercise Price shall be subject to adjustment from time to time as provided in this Section 2, and the number
of the Exercise Stock obtainable upon exercise of this Warrant shall be subject to adjustment from time to time as provided in
this Section 2.

 

2A.              Adjustment of Exercise Price and Number
of Shares upon Issuance of Common Stock.

 

(i)                
If and whenever, on or after the date hereof, the Company issues or sells, or in accordance with Section 2B is deemed
to have issued or sold, any shares of its common stock for a consideration per share less than the Exercise Price in effect immediately
prior to such time, then immediately upon such issue or sale the Exercise Price shall be reduced to the Exercise Price determined
by dividing:

 

		(1)	the sum of (x) the product derived by multiplying the Exercise Price in effect immediately prior to such issue or sale times
the number of shares of Common Stock Deemed Outstanding immediately prior to such issue or sale, plus (y) the consideration, if
any, received by the Company upon such issue or sale, by
	 	 	 

		(2)	the number of shares of Common Stock Deemed Outstanding immediately after such issue or sale.

 

(ii)              
Upon each such adjustment of the Exercise Price hereunder, the number of shares of the Exercise Stock acquirable upon exercise
of this Warrant shall be adjusted to the number of shares determined by multiplying the Exercise Price in effect immediately prior
to such adjustment by the number of the Exercise Stock acquirable upon exercise of this Warrant immediately prior to such adjustment
and dividing the product thereof by the Exercise Price resulting from such adjustment.

 

(iii)            
Notwithstanding the foregoing, no adjustment shall be made pursuant to this Section 2A or Section 2B with
respect to any of the following issuances or sales, or deemed issuances or sales:

 

		(1)	shares of the Company’s common stock, Options or Convertible Securities issued by reason of a dividend, stock split,
split-up or other distribution on shares of the Company’s common stock that is covered by Section 2D, 2E or 2F;
or
	 	 	 

    	- 4 -

     

    

 

		(2)	subject to the terms of this sub-clause (2), shares of the Company’s common stock actually issued pursuant to awards
or issuable upon the exercise of awards, in each case made pursuant to the Sterling Construction Company, Inc. Stock Incentive
Plan (the “Incentive Plan”) or any successor equity compensation plan adopted by the Company and approved by
the stockholders of the Company after the date hereof (a “Successor Equity Plan”), provided that (i)
such issuance is pursuant to the terms of such awards, (ii) such awards are issued at or above the then current Market Price for
the Company’s common stock and (iii) the aggregate number of shares of the Company’s common stock issued pursuant to
or issuable upon exercise of such awards (determined in accordance with the terms of the Incentive Plan or Successor Equity Plan,
as applicable, at the time of any such award) does not exceed an aggregate maximum amount equal the sum of (A) the four hundred
ninety-three thousand nine hundred twenty-one (493,921) shares of common stock that comprise the aggregate balance of shares not
yet issued under the Incentive Plan, plus (B) any shares issued or issuable pursuant to any such awards outstanding on the date
hereof that are hereafter forfeited and returned to the share pool of the Incentive Plan for subsequent issuance, plus (C) up to
an additional five hundred thousand (500,000) shares under the Incentive Plan (upon the amendment thereof in accordance with its
terms) or a Successor Equity Plan.

 

2B.               Effect on Exercise Price of Certain
Events. For purposes of determining the adjusted Exercise Price under Section 2A(i), the following shall be applicable:

 

(i)                
Issuance of Rights or Options. If the Company in any manner grants or sells any Options and the price per share for
which the Company’s common stock is issuable upon the exercise of such Options, or upon conversion or exchange of any Convertible
Securities issuable upon exercise of such Options, is less than the Exercise Price in effect immediately prior to the time of the
granting or sale of such Options, then the total maximum number of shares of the Company’s common stock issuable upon the
exercise of such Options, or upon conversion or exchange of the total maximum amount of such Convertible Securities issuable upon
the exercise of such Options, shall be deemed to be outstanding and to have been issued and sold by the Company at the time of
the granting or sale of such Options for such price per share. For purposes of this paragraph, the “price per share for which
the Company’s common stock is issuable upon exercise of such Options or upon conversion or exchange of such Convertible Securities”
is determined by dividing (A) the total amount, if any, received or receivable by the Company as consideration for the granting
or sale of such Options, plus the minimum aggregate amount of additional consideration payable to the Company upon the exercise
of all such Options, plus in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional
consideration, if any, payable to the Company upon the issuance or sale of such Convertible Securities and the conversion or exchange
thereof, by (B) the total maximum number of shares of the Company’s common stock issuable upon exercise of such Options or
upon the conversion or exchange of all such Convertible Securities issuable upon the exercise of such Options. No further adjustment
of the Exercise Price shall be made upon the actual issuance of such Company common stock or of such Convertible Securities upon
the exercise of such Options or upon the actual issuance of such Company common stock upon conversion or exchange of such Convertible
Securities.

 

    	- 5 -

     

    

 

(ii)              
Issuance of Convertible Securities. If the Company in any manner issues or sells any Convertible Securities and the
price per share for which the Company’s common stock is issuable upon conversion or exchange thereof is less than the Exercise
Price in effect immediately prior to the time of such issue or sale, then the maximum number of shares of the Company’s common
stock issuable upon conversion or exchange of such Convertible Securities shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the issue or sale of such Convertible Securities for such price per share. For the purposes
of this paragraph, the “price per share for which the Company’s common stock is issuable upon conversion or exchange
thereof” is determined by dividing (A) the total amount received or receivable by the Company as consideration for the issue
or sale of such Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Company
upon the conversion or exchange thereof, by (B) the total maximum number of shares of the Company’s common stock issuable
upon the conversion or exchange of all such Convertible Securities. No further adjustment of the Exercise Price shall be made upon
the actual issue of such common stock upon conversion or exchange of such Convertible Securities, and if any such issue or sale
of such Convertible Securities is made upon exercise of any Options for which adjustments of the Exercise Price had been or are
to be made pursuant to other provisions of this Section 2B, no further adjustment of the Exercise Price shall be made by
reason of such issue or sale.

 

(iii)            
Change in Option Price or Conversion Rate. If the purchase price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion or exchange of any Convertible Securities, or the rate at which any Convertible Securities
are convertible into or exchangeable for the Company’s common stock changes at any time, the Exercise Price in effect at
the time of such change shall be adjusted immediately to the Exercise Price which would have been in effect at such time had such
Options or Convertible Securities still outstanding provided for such changed purchase price, additional consideration or changed
conversion rate, as the case may be, at the time initially granted, issued or sold and the number of the Exercise Stock issuable
hereunder shall be correspondingly adjusted. For purposes of this Section 2B, if the terms of any Option or Convertible
Security which was outstanding as of the date of issuance of this Warrant are changed in the manner described in the immediately
preceding sentence, then such Option or Convertible Security and the Company’s common stock deemed issuable upon exercise,
conversion or exchange thereof shall be deemed to have been issued as of the date of such change; provided that no such
change shall at any time cause the Exercise Price hereunder to be increased.

 

    	- 6 -

     

    

(iv)            
Treatment of Expired Options and Unexercised Convertible Securities. Upon the expiration of any Option or the termination
of any right to convert or exchange any Convertible Securities without the exercise of such Option or right, the Exercise Price
then in effect and the number of the Exercise Stock acquirable hereunder shall be adjusted immediately to the Exercise Price and
the number of shares which would have been in effect at the time of such expiration or termination had such Option or Convertible
Securities, to the extent outstanding immediately prior to such expiration or termination, never been issued. For purposes of this
Section 2B the expiration or termination of any Option or Convertible Security which was outstanding as of the date of issuance
of this Warrant shall not cause the Exercise Price hereunder to be adjusted unless, and only to the extent that, a change in the
terms of such Option or Convertible Security caused it to be deemed to have been issued after the date of issuance of this Warrant.

 

(v)              
Calculation of Consideration Received. If any of the Company’s common stock, Options or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor shall be deemed to be the
net amount received by the Company therefor. In case any of the Company’s common stock, Options or Convertible Securities
are issued or sold for any consideration other than cash, the amount of the consideration other than cash received by the Company
shall be the fair value of such consideration, except where such consideration consists of securities, in which case the amount
of consideration received by the Company shall be the Market Price thereof as of the date of receipt. In case any of the Company’s
common stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity the amount of consideration therefor shall be deemed to be the fair value of such
portion of the net assets and business of the non-surviving entity as is attributable to such Company common stock, Options or
Convertible Securities, as the case may be. The fair value of any consideration other than cash or securities shall be determined
jointly by the Company and the Registered Holders of Warrants representing a majority of the Exercise Stock obtainable upon exercise
of such Warrants. If such parties are unable to reach agreement within a reasonable period of time, such fair value shall be determined
by an appraiser jointly selected by the Company and the Registered Holders of Warrants representing a majority of the Exercise
Stock obtainable upon exercise of such Warrants. The determination of such appraiser shall be final and binding on the Company
and the Registered Holders of the Warrants, and the fees and expenses of such appraiser shall be paid by the Company.

 

(vi)            
Integrated Transactions. In case any Option is issued in connection with the issue or sale of other securities of
the Company, together comprising one integrated transaction in which no specific consideration is allocated to such Options by
the parties thereto, the Options shall be deemed to have been issued without consideration.

 

(vii)          
Treasury Shares. The number of shares of the Company’s common stock outstanding at any given time does not
include shares owned or held by or for the account of the Company or any of its subsidiaries, and the disposition of any shares
so owned or held shall be considered an issue or sale of the Company’s common stock.

 

2C.            
Record Date. If the Company takes a record of the holders of the Company’s common stock for the purpose of
entitling them (A) to receive a dividend or other distribution payable in the Company’s common stock, Options or in Convertible
Securities or (B) to subscribe for or purchase the Company’s common stock, Options or Convertible Securities, then such record
date shall be deemed to be the date of the issue or sale of the shares of the Company’s common stock deemed to have been
issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such
right of subscription or purchase, as the case may be.

 

    	- 7 -

     

    

 

2D.            Subdivision or Combination of Common
Stock. If the Company at any time subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more
classes of its outstanding shares of common stock into a greater number of shares, the Exercise Price in effect immediately prior
to such subdivision shall be proportionately reduced and the number of shares of the Exercise Stock obtainable upon exercise of
this Warrant shall be proportionately increased. If the Company at any time combines (by reverse stock split or otherwise) one
or more classes of its outstanding shares of common stock into a smaller number of shares, the Exercise Price in effect immediately
prior to such combination shall be proportionately increased and the number of shares of the Exercise Stock obtainable upon exercise
of this Warrant shall be proportionately decreased.

 

2E.            
Reorganization, Reclassification, Consolidation, Merger or Sale. Any recapitalization, reorganization, reclassification,
spin-off, consolidation, merger or sale of all or substantially all of the Company’s assets with, into or to another Person
or other transaction, which is effected in such a way that holders of the Company’s common stock are entitled to receive
(either directly or upon subsequent liquidation) stock or other equity interests, securities, assets or other property with respect
to or in exchange for such common stock is referred to herein as an “Organic Change.” Prior to the consummation
of any Organic Change that does not constitute a Sale of the Company, the Company shall make appropriate provision (in form and
substance reasonably satisfactory to the Registered Holder) to ensure that the Registered Holder of this Warrant shall thereafter
have the right to acquire and receive (upon exercise of such Warrant and subject to the last sentence of this Section 2E),
in lieu of or in addition to (as the case may be) the common stock immediately theretofore acquirable and receivable upon the exercise
of this Warrant, such shares of stock or equity interests, securities, assets or other property as would have been issued or payable
in such Organic Change (as if this Warrant had been exercised immediately prior to such Organic Change) with respect to or in exchange
for the Company’s common stock immediately theretofore acquirable and receivable upon exercise of this Warrant had such Organic
Change not taken place. In any such case, the Company shall make appropriate provision (in form and substance reasonably satisfactory
to the Registered Holder) with respect to such holder’s rights and interests to ensure that the provisions of this Section
2 and Section 3 shall thereafter be applicable to this Warrant (including, in the case of any such consolidation, merger
or sale in which the successor entity or purchasing entity is other than the Company, an immediate adjustment in the number of
shares of common stock acquirable and receivable upon exercise of this Warrant based on the relative value of the Company’s
common stock and the common stock or other equity interests of the successor entity or purchasing entity). The Company shall not
effect any such consolidation, merger or sale unless, prior to the consummation thereof, the successor entity (if other than the
Company) resulting from consolidation or merger or the entity purchasing such assets assumes by written instrument (in form and
substance reasonably satisfactory to the Registered Holder) the obligation to deliver to each such holder (upon exercise of such
Warrant and subject to the last sentence of this Section 2E) such shares of stock or equity interests, securities, assets
or other property as, in accordance with the foregoing provisions, such holder may be entitled to acquire. The Company, its successor
entity or the purchaser entity, as applicable, shall promptly issue to the Registered Holder the aggregate shares of the Company’s
common stock or equity interests, securities, assets or other property obtainable under this Warrant following such recapitalization,
reorganization, reclassification, consolidation, merger or sale. Notwithstanding anything to the contrary in this Section 2E,
the Registered Holder may, in its sole discretion, elect, pursuant to Section 1.A(vii), to receive cash in certain Organic
Changes.

 

    	- 8 -

     

    

 

2F.  Certain
Events. If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other
rights with equity features), then the Company’s board of directors shall make an appropriate adjustment in the Exercise
Price and the number of shares of the Exercise Stock obtainable upon exercise of this Warrant so as to protect the rights of the
holders of the Warrants.

 

2G.           
Notices. Promptly upon any adjustment of the Exercise Price and/or number of shares of Exercise Stock, the Company
shall give written notice thereof to the Registered Holder, setting forth in reasonable detail and certifying the calculation of
such adjustment. (i)                
The Company shall give written notice to the Registered Holder at least 30 days prior to the date on which the Company closes
its books or takes a record (A) with respect to any dividend or distribution upon its common stock, (B) with respect to any pro
rata subscription offer (including with respect to any options, convertible securities or rights to purchase stock, warrants, securities
or other property) to holders of common stock or (C) for determining rights to vote with respect to any Organic Change, Sale of
the Company, dissolution or liquidation.

 

2H.           
No Impairment.  The Company shall not avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed by the Company under this Section 2, but shall at all times
in good faith assist in carrying out of all the provisions of this Section 2 and in taking all such action as may be necessary
or appropriate to protect the Registered Holder’s rights under this Section 2 against impairment.

 

2I.              
Restricted Actions. For so long as the Registered Holder holds any portion of this Warrant (and/or the Exercise Stock
issued as a result of exercise thereof), the Company shall not, and shall cause its subsidiaries not to become subject to (including,
without limitation, by way of amendment to or modification of) any agreement or instrument which by its terms would (under any
circumstances) restrict the right of the Company or any of its subsidiaries to fulfill its obligations under this Warrant.

 

2J.  
Expenses. The Company shall prepare, issue and deliver at its own expense any new Warrant or Warrants required
to be issued hereunder.

 

Section 3.   
Dividends and Distributions. If the Company declares or pays a dividend or distribution upon its common stock (a
“Distribution”), then the Company shall pay to the Registered Holder (or any Person designated by the Registered
Holder) at the time of payment thereof the Distribution which would have been paid to the Registered Holder on the Exercise Stock
had this Warrant been fully exercised immediately prior to the date on which a record is taken for such Distribution or, if no
record is taken, the date as of which the record holders of common stock entitled to such Distribution are to be determined.

 

    	- 9 -

     

    

Section 4.   
Representations and Warranties of the Company. The Company represents and warrants to the Registered Holder as follows,
as of the Issuance Date:

 

(i)                
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.
The Company has full power and authority to conduct its business as it is being conducted and to own or use the properties and
assets that it purports to own or use. The Company has full power and authority to execute and deliver this Warrant and the Registration
Rights Agreement, to perform its obligations hereunder (including issuing the Exercise Stock upon exercise of this Warrant) and
thereunder and to consummate the transactions contemplated hereby and thereby, and all action required on the part of the Company
for such execution, delivery and performance has been duly and validly taken. Each of this Warrant and the Registration Rights
Agreement constitutes the valid and legally binding obligation of the Company enforceable in accordance with its terms and conditions
(except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and by general equitable principles).

 

(ii)              
Neither the execution and delivery of this Warrant or the Registration Rights Agreement nor the consummation of the transactions
contemplated hereby or thereby will (A) violate any Applicable Law or other restriction of any governmental authority to which
the Company is subject or any provision of the Company’s certificate of incorporation or bylaws, or (B) conflict with, result
in a breach of, constitute a default under, result in the acceleration of, or create in any Person the right to accelerate, terminate,
modify or cancel any agreement, contract, lease, license, instrument or other arrangement to which the Company is a party or by
which it is bound or to which any of its assets is subject. The Company is not required to give any notice to, make any filing
with or obtain any authorization, consent or approval of any governmental authority or other Person in order for the parties to
enter into this Warrant or the Registration Rights Agreement and consummate the transactions contemplated hereby and thereby, other
than (y) the filing with the SEC of the registration statement contemplated by the Registration Rights Agreement and such registration
statement being declared effective by the SEC and (z) the filing of a Form 8-K with the SEC.

 

(iii)            
The Company has provided to the Registered Holder true and correct copies of the Company’s certificate of incorporation
and bylaws.

The Company shall reaffirm to the Registered Holder
the representations and warranties set forth in this Section 4 as of each Exercise Time.

 

Section 5.   
Representations and Warranties of the Registered Holder. The Registered Holder represents and warrants to the Company
as follows, as of the Issuance Date:

 

(i)                
Purchase for Own Account. This Warrant and the securities to be acquired upon exercise of this Warrant by Registered
Holder are being acquired for investment for Registered Holder’s account, not as a nominee or agent, and not with a view
to the public resale or distribution within the meaning of the Securities Act.

 

    	- 10 -

     

    

 

(ii)              
Disclosure of Information. Registered Holder is aware of the Company’s business affairs and financial condition
and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment
decision with respect to the acquisition of this Warrant and its underlying securities.

 

(iii)            
Investment Experience. Registered Holder understands that the purchase of this Warrant and its underlying securities
involves substantial risk. Registered Holder has experience as an investor in securities of companies similar to the Company and
acknowledges that Registered Holder can bear the economic risk of such Registered Holder’s investment in this Warrant and
its underlying securities and has such knowledge and experience in financial or business matters that Registered Holder is capable
of evaluating the merits and risks of its investment in this Warrant and its underlying securities.

 

(iv)            
Accredited Investor Status. Registered Holder is an “accredited investor” within the meaning of Regulation
D promulgated under the Securities Act.

 

(v)              
The Securities Act. Registered Holder understands that this Warrant and the Exercise Stock have not been registered
under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the
bona fide nature of the Registered Holder’s investment intent as expressed herein. Registered Holder understands that this
Warrant and the Exercise Stock must be held indefinitely unless subsequently registered under the Securities Act and qualified
under applicable state securities laws, or unless exemption from such registration and qualification are otherwise available. Registered
Holder is aware of the provisions of Rule 144 promulgated under the Securities Act.

The Purchaser shall reaffirm to the Company the
representations and warranties set forth in this Section 5 (as to Purchaser) as of each Exercise Time.

 

Section 6.   
Definitions. For the purposes of this Warrant, the following terms shall have the meanings set forth below:

 

“Affiliate” means with respect
to any Person, any Person: (a) which directly or indirectly through one or more intermediaries controls, or is controlled by, or
is under common control with, such Person; (b) which beneficially owns or holds 50% or more of any class of the voting securities
of such Person; (c) of which 50% or more of the voting securities is beneficially owned or held by such Person; (d) that is a trust
formed and operated for the benefit of such Person or one of such Person’s Affiliates, or that is directly or indirectly
through one or more intermediaries controlled by such a trust; or (e) that is the beneficiary (or an Affiliate of the beneficiary)
of a trust that directly or indirectly through one or more intermediaries controls such Person. The term “control”
means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a
Person, whether through the ownership of voting securities, by contract or otherwise.

 

    	- 11 -

     

    

 

“Allocation Percentage” means
the fraction obtained by dividing (a) the number of shares of Exercise Stock, by (b) one million (1,000,000), in each case as adjusted
pursuant to Section 2 hereof from time to time.

 

“Applicable Law” means any
applicable statute, law, principle of common law, ordinance, policy, guidance, rule, administrative interpretation, regulation
or Order of any governmental authority.

 

“Common Stock Deemed Outstanding”
means, at any given time, the number of shares of the Company’s common stock actually outstanding at such time, plus the
number of shares of the Company’s common stock deemed to be outstanding pursuant to Sections 2B(i) and 2B(ii) regardless
of whether the Options or Convertible Securities are actually exercisable at such time.

 

“Convertible Securities”
means any stock or securities (directly or indirectly) convertible into or exchangeable for the Company’s common stock.

 

“Exercise Price” means $10.25
per share, as may be further adjusted from time to time in accordance herewith.

 

“Expiration Date” means the
5th anniversary of the Issuance Date.

 

“Market Price” means as to
any security the average of the closing prices of such security's sales on all domestic securities exchanges on which such security
may at the time be listed, or, if there have been no sales on any such exchange on any day, the average of the highest bid and
lowest asked prices on all such exchanges at the end of such day, or, if on any day such security is not so listed, the average
of the highest bid and lowest asked prices on such day in the domestic over-the-counter market as reported by Pink OTC Markets,
Inc., or any similar successor organization, in each such case averaged over a period of 21 days consisting of the day as of which
“Market Price” is being determined and the 20 consecutive business days prior to such day; provided that if such security
is listed on any domestic securities exchange the term “business days” as used in this sentence means business days
on which such exchange is open for trading. If at any time such security is not listed on any domestic securities exchange or quoted
in the domestic over-the-counter market, the “Market Price” shall be the fair value thereof determined jointly by the
Company and the Registered Holder of Warrants representing a majority of the Exercise Stock purchasable upon exercise of all the
Warrants then outstanding (without applying any marketability, minority or other discounts); provided that if such parties are
unable to reach agreement within a reasonable period of time, such fair value shall be determined (without applying any marketability,
minority or other discounts) by an appraiser jointly selected by the Company and the Registered Holders of Warrants representing
a majority of the Exercise Stock purchasable upon exercise of all the Warrants then outstanding. The determination of such appraiser
shall be final and binding on the Company and the Registered Holders of the Warrants, and the fees and expenses of such appraiser
shall be paid by the Company.

 

“Options” means any rights
or options to subscribe for or purchase the Company’s common stock or Convertible Securities.

 

    	- 12 -

     

    

 

“Order” means any order,
writ, injunction, directive, judgment, decree or other legal requirement imposed by any governmental authority.

 

“Person” means an individual,
a partnership, a joint venture, a corporation, a limited liability company, a trust, an unincorporated organization or a government
or any department or agency thereof.

 

“Sale of the Company” means
(i) any sale or transfer by the Company of all or substantially all of its assets on a consolidated basis, (ii) any consolidation,
merger or reorganization of the Company with or into any other entity or entities as a result of which any Person or group other
than the current stockholders of the Company and their respective Affiliates obtains possession of the voting power to appoint
a majority of the surviving entity’s managers, board of directors or similar governing body, or (iii) any transfer to any
third party of equity interests in the Company by the stockholders thereof as a result of which any Person or group other than
the current stockholders of the Company and their respective Affiliates obtains possession of the voting power to appoint a majority
of the Company’s board of directors; in each of the foregoing (i), (ii) and (iii), where the consideration for such transaction
is paid solely in cash.

 

“Securities Act” means the
Securities Act of 1933, as amended.

 

“SEC” means the Securities
and Exchange Commission.

 

Section 7.   
No Voting Rights; Limitations of Liability. This Warrant shall not entitle the holder hereof to any voting rights
or other rights of a stockholder of the Company. Except for the automatic “net basis” exercise provisions expressly
set forth in this Warrant and the automatic conversion set forth in Section 1A, no provision hereof, in the absence of affirmative
action by the Registered Holder to purchase the Exercise Stock, and no enumeration herein of the rights or privileges of the Registered
Holder shall give rise to any liability of such holder for the Exercise Price of shares of the Exercise Stock acquirable by exercise
hereof or as a stockholder of the Company.

 

Section 8.   
Transferability. The Registered Holder shall be entitled to transfer any interest in this Warrant without the prior
written consent of the Company. Any transfer of this Warrant shall be effective upon execution of an assignment substantially
in the form set forth on Exhibit I hereto and delivery of such executed assignment to the Company. Notwithstanding the
foregoing, neither this Warrant nor the Exercise Stock may be transferred or assigned in whole or in part except in compliance
with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery
of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the
Company). The Company shall not require Registered Holder to provide an opinion of counsel if the transfer is to any Affiliate
of Registered Holder, provided that any such transferee is an “accredited investor” as defined in Regulation
D promulgated under the Securities Act. Additionally, the Company shall also not require an opinion of counsel if there is no
material question as to the availability of Rule 144 promulgated under the Securities Act. The Exercise Stock shall be notated
with a legend in substantially the following form:

 

    	- 13 -

     

    

 

THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND,
EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT DATED [____], 2017, SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER THE ACT AND LAWS OR AN EXEMPTION THEREFROM.

 

Section 9.   
Warrant Exchangeable for Different Denominations. This Warrant is exchangeable, upon the surrender hereof by the
Registered Holder at the principal office of the Company, for new Warrants of like tenor representing in the aggregate the rights
hereunder, and each such new Warrant shall represent such portion of such rights as is designated by the Registered Holder at the
time of such surrender. [___], 2017, the date on which the Company initially issues this Warrant, shall be deemed to be the “Issuance
Date” hereof regardless of the number of times new certificates representing the unexpired and unexercised rights formerly
represented by this Warrant shall be issued. All Warrants representing portions of the rights hereunder are included in the definition
of this “Warrant” hereunder.

 

Section 10.Replacement. Upon receipt
of evidence reasonably satisfactory to the Company (an affidavit of the Registered Holder shall be satisfactory) of the ownership
and the loss, theft, destruction or mutilation of any certificate evidencing this Warrant, and in the case of any such loss, theft
or destruction, upon receipt of indemnity reasonably satisfactory to the Company (provided that if the holder is a financial institution
or other institutional investor its own agreement shall be satisfactory) or, in the case of any such mutilation upon surrender
of such Warrant, the Company shall (at its expense) execute and deliver in lieu of such Warrant a new Warrant of like kind representing
the same rights represented by such lost, stolen, destroyed or mutilated Warrant and dated the date of such lost, stolen, destroyed
or mutilated Warrant.

 

Section 11.Notices. Except as expressly
set forth to the contrary in this Warrant, all notices, requests or consents provided for or permitted to be given under this Warrant
must be in writing and shall be deemed delivered (a) one business day after depositing such writing with a reputable overnight
courier for next day delivery, (b) three business days after depositing such writing in the United States mail, postage paid, and
registered or certified with return receipt requested or (c) upon delivering such writing to the recipient in person, by courier
or by facsimile transmission or email (if the facsimile or email is sent during normal business hours of the recipient; but if
not, then such notice shall be deemed given on the next business day). All notices, requests and consents to be sent to the Registered
Holder must be sent to or made at Oaktree Capital Management, L.P., 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071,
Attention: [____],[____]@[____].com and to Kirkland & Ellis LLP, 333 South Hope Street, Los Angeles, CA 90071, Attention: Damon
R. Fisher, P.C., dfisher@kirkland.com, or such other address as the Registered Holder may specify by notice to the Company. Any
notice, request or consent to the Company must be sent to or made at Sterling Construction Company, Inc., 1800 Hughes Landing Boulevard,
Suite 250, The Woodlands, TX 77380, Attention: Ronald A. Ballschmiede, CFO, ron.ballschmiede@strlco.com.

 

Section 12.Amendment and Waiver. The
provisions of this Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act herein
required to be performed by it, only if the Company has obtained the prior written consent of the Registered Holders of Warrants
representing a majority of the Exercise Stock obtainable upon exercise of the Warrants.

 

    	- 14 -

     

    

 

Section 13.Severability. Wherever possible,
each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any
provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Warrant.

 

Section 14.Descriptive Headings; Governing
Law. The descriptive headings of the several sections and paragraphs of this Warrant are inserted for convenience only and
do not constitute a part of this Warrant. The corporate laws of the State of Delaware shall govern all issues concerning the relative
rights of the Company and its members. All issues concerning the construction, validity, enforcement and interpretation of this
Warrant shall be governed by the internal law of the State of Delaware, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of Delaware.

 

Section 15.Limitation on Exercise. 

 

15A.       
Limitations. Notwithstanding anything to the contrary contained herein, at any time when the exercise of this Warrant
at the Exercise Price would result in an effective purchase price per share for the common stock of the Company that is less than
the greater of the book value or market value per share of the Company’s common stock on the trading day immediately preceding
the date of this Warrant, the maximum number of shares of common stock of the Company that may be purchased pursuant to this Warrant
shall equal the product of (a) 19.99% of the shares of the Company’s common stock outstanding as of the last business day
prior to the date of this Warrant, multiplied by (b) the Allocation Percentage. For the avoidance of doubt, as of the last business
day prior to the date of this Warrant, [25,051,045] shares of the Company’s common stock were outstanding. Unless the Purchaser
shall have received the prior approval of the Company’s stockholders, the Purchaser shall only be permitted to purchase up
to a number of shares of the Company’s common stock pursuant to this Warrant such that the beneficial ownership of the Company’s
common stock by the Purchaser and its Affiliates, on a pro forma basis, would represent no greater than 19.99% of the shares of
the Company’s common stock outstanding after giving effect to the exercise of this Warrant and any other transactions that
would occur concurrently therewith, after giving effect to all applicable adjustments under this Warrant.

 

    	- 15 -

     

    

 

15B.        
Additional Payment. If the number of shares of common stock that may be purchased pursuant to this Warrant is limited
by the provisions of Section 15A, then the Company shall make an additional cash payment to the Purchaser, within three business
days of such exercise, in an amount equal to the product of (a) the number of shares that were not able to be issued upon such
exercise as a result of Section 15A, multiplied by (b) the absolute value of the difference between the closing price per share
of the Company’s common stock on the domestic securities exchange on which the Company’s common stock is listed (or,
if the Company’s common stock is not listed, the average of the highest bid and lowest asked prices in the Pink OTC Markets)
on the date of such exercise request and the Exercise Price. Upon the payment of the amount contemplated by this Section 15B, the
Warrant shall be deemed to have been exercised for the entire number of shares indicated in the Exercise Agreement.

 

(Signature Page Follows)

 

 

 

 

 

 

    	- 16 -

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Warrant to be signed and attested by its duly authorized officer and to be dated the Issuance Date hereof.

 

 

	 	 	Sterling Construction Company, Inc.
	 	 	 
	 	 	By: 	                                               
	 	 	Name: 	 
	 	 	Title:	 

 

 

 

 
 

 

 

     

     

    

 

Accepted and Agreed:

 

[OAKTREE SIG BLOCK]

 

	By: 	 	 	 
	Name: 	 	 	 
	Title:	 	 
	 	 	 
	 	 	 

 

 

 

 

 

 

     

     

    

 

EXHIBIT I

 

ASSIGNMENT

 

FOR VALUE RECEIVED, the undersigned hereby sells,
assigns and transfers all of the rights of the undersigned under the attached Warrant (Certificate No. W- ), with respect to the
number of shares of common stock of Sterling Construction Company, Inc. covered thereby set forth below, unto the assignee set
forth below:

 

	Names of Assignee	Address	No. of Stock
	 	 	 

 

Each assignee listed above hereby acknowledges
and agrees to be bound by all terms and conditions of the attached Warrant as if such assignee were signatory to this Warrant.

 

 

	 	 	[NAME OF HOLDER]
	 	 	 
	 	 	By:  	 
	 	 	Name: 	 
	 	 	Title:
	 	 	 
	Agreed and acknowledged by:	 	 
	 	 	 
	[NAME OF ASSIGNEE]	 	 
	 	 	 
	By:  	                                            	 	 
	Name: 	 	 
	Title: 	 	 
	 	 	Date: 	 
	 	 	 
	 	 	 
	 	 	 

 

 

 

 

 

     

     

    

 

EXHIBIT II

 

EXERCISE AGREEMENT

 

To: Sterling Construction Company, Inc.

 

Dated: ________________

 

The undersigned, pursuant to the provisions
set forth in the attached Warrant (Certificate No. W-    ), hereby agrees to subscribe for the purchase
of ___ shares of common stock of Sterling Construction Company, Inc., a Delaware corporation, covered by such Warrant [and makes
payment herewith in full therefor at the price per unit provided by such Warrant] [and elects to effect such exercise on a “net
basis”].

 

	 	 	[NAME OF HOLDER]
	 	 	 
	 	 	By:  	 
	 	 	Name: 	 
	 	 	Title:
	 	 	 
	 	 	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]